Today, chronic limb threatening ischemia (CLTI) due to diabetic arterial disease is a major worldwide cause of morbidity and mortality,1,2 affecting a large number of patients and can lead to severe disabilities.
Revascularization is the key therapy in these patients because re-establishing adequate blood supply to the foot is necessary to relieve clinical symptoms related to CLTI and to avoid major amputations.3
An endovascular-first approach has increased in acceptance for the treatment of diabetic patients with CLTI due to good clinical results.4-5
At the same time, rapidly evolving technologies in diagnostics and devices offer new opportunities to improve treatment and to address unmet needs in this vulnerable population. 6
We are striving for technical improvements and refinements to support endovascular treatment of BTK and BTA atherosclerotic disease.
NaviCrossTM Support Catheter is dedicated to reach and cross complex lesions in challenging anatomy.
The addition of Radifocus Glidewire Advantage TrackTM to your toolkit provides with additional performance, for the most challenging cases.
The addition of an extra-stiff stainless-steel proximal core shaft makes a guidewire that easily navigates, while providing with excellent pushability and support
Available in 0.018’’ and 0.014’’ sizes, Radifocus Glidewire Advantage TrackTM supports your success in both, femoro-popliteal and below-the-knee interventions
Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet. 2005;336:1719-1724.
Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg. 2006;32:484-490.
Ferraresi R, Palena LM, Mauri G, et al. Tips and tricks for a correct endo approach. J Cardiovasc Surg. 2013;54:685-711.
Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29:620-627.
Palena LM, Manzi M, Retrograde Transmetatarsal Artery Access: Below-the-ankle angioplasty for foot preservation in CLI patients. Endovasc Today. 2014
Michael S. Conte et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg (2019) 58, S1-S109.
Radifocus® Glidewire Advantage™
Discover our clinical evidence and case studies concerning this topic.
Featured product: NaviCross® Support Catheter
Our sales representatives are here for you.
Thank you for contacting us!
We typically respond within 2 business days and will come back to you as soon as possible.
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This is HCP only content
website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.
Essential cookies to ensure the website functions well.
Cookies to help us measure the general use of our website.
Cookies that save personal information while browsing.